1.Caplan, LR. Embolic particles. In Caplan, LR, Manning, W (eds), Brain Embolism. New York: Informa Healthcare, 2006, pp 259–275.
2.Molina, C, Alexandrov, A. Transcranial Doppler ultrasound. In Caplan, LR, Manning, W (eds), Brain Embolism. New York: Informa Healthcare, 2006, pp 113–128.
3.Caplan, LR. Brain embolism, revisited. Neurology 1993;43:1281–1287.
4.Caplan, LR. Brain embolism. In Caplan, LR, Hurst, JW, Chimowitz, M (eds), Clinical Neurocardiology. New York: Marcel Dekker, 1999, pp 35–185.
5.Markus, HS. Transcranial Doppler detection of circulating cerebral emboli, a review. Stroke 1993;24:1246–1250.
6.Sliwka, U, Job, F-P, Wissuwa, D, et al. Occurrence of transcranial Doppler high-intensity transient signals in patients with potential cardiac sources of embolism, a prospective study. Stroke 1995;26:2067–2070.
7.Daffertshofer, M, Ries, S, Schminke, U, Hennerici, M. High-intensity transient signals in patients with cerebral ischemia. Stroke 1996;27:1844–1849.
8.Sliwka, U, Lingnau, A, Stohlmann, W-D, et al. Prevalence and time course of microembolic signals in patients with acute strokes, a prospective study. Stroke 1997;28:358–363.
9.Babikian, VL, Caplan, LR. Brain embolism is a dynamic process with variable characteristics. Neurology 2000;54:797–801.
10.Caplan, LR. Recipient artery. In Caplan, LR, Manning, W (eds), Brain Embolism. New York: Informa Healthcare, 2006, pp 31–59.
11.Mohr, JP, Caplan, LR, Melski, JW, et al. The Harvard Cooperative Stroke Registry: A prospective registry. Neurology 1978;29:754–762.
12.Caplan, LR, Hier, DB, D’Cruz, I. Cerebral embolism in the Michael Reese Stroke Registry. Stroke 1983;14:530–536.
13.Mohr, JP, Gautier, JC, Hier, DB, Stein, RW. Middle cerebral artery. In Barnett, HJM, Mohr, JP, Stein, BM, Yatsu, FM (eds), Stroke, Pathophysiology, Diagnosis, and Management, Vol 1. New York: Churchill Livingstone, 1986, pp 377–450.
14.Minematsu, K, Yamaguchi, T, Omae, T. “Spectacular shrinking deficit”: Rapid recovery from a major hemispheric syndrome by migration of an embolus. Neurology 1992;42:157–162.
15.Bogousslavsky, J, van Melle, G, Regli, F. The Lausanne Stroke Registry: Analysis of 1000 consecutive patients with first stroke. Stroke 1988;19:1083–1092.
16.Gacs, G, Merer, FT, Bodosi, M. Balloon catheter as a model of cerebral emboli in humans. Stroke 1982;13:39–42.
17.Helgason, C. Cardioembolic stroke topography and pathogenesis. Cerebrovasc Brain Metab Rev 1992;4:28–58.
18.Caplan, LR. Vertebrobasilar Ischemia and Hemorrhage: Clinical Findings, Diagnosis, and Management of Posterior Circulation Disease. Cambridge: Cambridge University Press, 2015.
19.Caplan, LR. Top of the basilar syndrome: Selected clinical aspects. Neurology 1980;30:72–79.
20.Mehler, MF. The rostral basilar artery syndrome: Diagnosis, etiology, prognosis. Neurology 1989;39:9–16.
21.Caplan, LR. Cerebellar infarcts: Key features. Rev Neurol Dis 2005;2:51–60.
22.Lodder, J, Krijne-Kubat, B, Broekman, J. Cerebral hemorrhagic infarction at autopsy: Cardiac embolic cause and the relationship to the cause of death. Stroke 1986;17:626–629.
23.Hart, RG, Easton, JD. Hemorrhagic infarcts. Stroke 1986;17:586–589.
24.Timsit, SG, Sacco, RL, Mohr, JP, et al. Brain infarction severity differs according to cardiac or arterial embolic source. Neurology 1993;43:728–733.
25.Bladin, CF. Seizures After Stroke. Melbourne: University of Melbourne, 1997. Thesis.
26.Kittner, SJ, Sharkness, CM, Price, TR, et al. Infarcts with a cardiac source of embolism in the NINCDS Stroke Data Bank: Historical features. Neurology 1990;40:281–284.
27.Hinton, RC, Kistler, JP, Fallon, JR, Friedlich, AL, Fisher, CM. Influence of etiology of atrial fibrillation on incidence of systemic embolism. Am J Card 1977;40:509–513.
28.Abboud, H, Labreuche, J, Gongora-Riverra, F, et al. Prevalence and determinants of subdiaphragmatic visceral infarction in patients with fatal stroke. Stroke 2007;38:1442–1446.
29.Ringelstein, EB, Koschorke, S, Holling, A, et al. Computed tomographic patterns of proven embolic brain infarctions. Ann Neurol 1989;26:759–765.
30.Viehman, JA, Saver, JL, Liebeskind, DS, et al. Utility of urinalysis in discriminating cardioembolic stroke mechanism. Arch Neurol 2007;64:667–670.
31.Slaoui, T, Klein, IF, Guidoux, C, et al. Prevalence of subdiaphragmatic visceral infarction in cardioembolic stroke. Neurology 2010;74:1030–1032.
32.Ringelstein, EB, Koschorke, S, Holling, A, et al. Computed tomographic patterns of proven embolic brain infarctions. Ann Neurol 1989;26:759–765.
33.Fisher, CM, Adams, R. Observations on brain embolism with special reference to the mechanism of hemorrhagic infarction. J Neuropathol Exp Neurol 1951;10:92–93.
34.Fisher, CM, Adams, RD. Observations on brain embolism with special reference to hemorrhagic infarction. In Furlan, AJ (ed), The Heart and Stroke. London: Springer, 1987 pp 17–36.
35.Yamaguchi, T, Minematsu, K, Choki, JI, Ikeda, M. Clinical and neuroradiological analysis of thrombotic and embolic cerebral infarction. Jpn Circ J 1984;48:50–58.
36.Okada, Y, Yamaguchi, T, Minematsu, K, et al. Hemorrhagic transformation in cerebral embolism. Stroke 1989;20:598–603.
37.Pessin, MS, Estol, C, Lafranchise, F, Caplan, LR. Safety of anticoagulation after hemorrhagic infarction. Neurology 1993;43:1298–1303.
38.Chaves, CJ, Pessin, MS, Caplan, LR, et al. Cerebellar hemorrhagic infarction. Neurology 1996;46:346–349.
39.Garcia, J, Ho, K-L, Caccamo, DV. Intracerebral hemorrhage: Pathology of selected topics. In Kase, CS, Caplan, LR (eds), Intracerebral Hemorrhage. Boston: Butterworth–Heinemann, 1994, pp 45–72.
40.Fieschi, C, Argentino, C, Lenzi, G, et al. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 1989;91:311–322.
41.del Zoppo, GJ, Poeck, K, Pessin, MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78–86.
42.Wolpert, SM, Bruckmann, H, Greenlee, R, Wechsler, L, Pessin, MS, del Zoppo, GJ. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. AJNR Am J Neuroradiol 1993;14:3–13.
43.Dalal, P, Shah, P, Sheth, S, et al. Cerebral embolism: Angiographic observations on spontaneous clot lysis. Lancet 1965;1:61–64.
44.Liebeskind, A, Chinichian, A, Schechter, M. The moving embolus seen during cerebral angiography. Stroke 1971;2:440–443.
45.Caplan, LR, Allam, GJ, Teal, PA. The moving embolus. J Neurimag 1993;3:195–197.
46.Sharma, VK, Tsivgoulis, G, Lao, AY, Alexandrov, AV. Role of transcranial Doppler ultrasonography in evaluation of patients with cerebrovascular disease. Curr Neurol Neurosci Rep 2007;7:8–20.
47.Thomassen, L, Waje-Andreassen, U, Naess, H, et al. Doppler ultrasound and clinical findings in patients with acute ischemic stroke treated with thrombolysis. Eur J Neurol 2005;12:462–465.
48.Molina, CA, Alexandrov, AV, Demchuk, AM, et al. Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke 2004;35:151–156.
49.Askevold, ET, Naess, H, Thomassen, L. Predictors of recanalization after intravenous thrombolysis in acute ischemic stroke. J Stroke Cerebrovasc Dis 2007;16:21–24.
50.Georgiadis, D, Lindner, A, Manz, M, et al. Intracranial microembolic signals in 500 patients with potential cardiac or carotid embolic source and in normal controls. Stroke 1997;28:1203–1207.
51.Cho, K-H, Kim, JS, Kwon, SU, Cho, A-H, Kang, D-W. Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes. Stroke 2005;36:2379–2383.
52.Kimura, K, Iguchi, V, Shibazaki, K, Watanabe, M, Iwanga, T, Aoki, J. M1 susceptiblity vessel sign on T2* as a strong predictor for no early recanalization after IV – t-PA in acute ischemic stroke. Stroke 2009;40:3130–3132.
53.Yamamoto, N, Satomi, J, Tada, Y, et al. Two-layered susceptibility vessel sign on 3-Tesla T2*-weighted imaging is a predictive biomarker of stroke subtype. Stroke 2015;46:269–271.
54.Liebeskind, DS, Sanossian, N, Yong, WH, et al. CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke 2011;42:1237–1243.
55.Caplan, LR. Of birds and nests and brain emboli. Rev Neurol 1991;147:265–273.
56.Caplan, LR, Manning, W. Cardiac sources of embolism: The usual suspects. In Caplan, LR, Manning, W (eds), Brain Embolism. New York: Informa Healthcare, 2006, pp 129–159.
57.Manning, W. Cardiac sources of embolism: Pathophysiology and identification. In Caplan, LR, Manning, W (eds), Brain Embolism. New York: Informa Healthcare, 2006, pp 161–186.
58.Virchow, R. Gesammelte Abhandlungen zur Wissenschaftlichenmedtezin. Frankfurt: Meidinger Sohn, 1856, pp 219–732.
59.Harker, LA, Slichter, SL. Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. N Engl J Med 1970;283:1302–1305.
60.Baumgartner, HR, Haudenschild, C. Adhesion of platelets to subendothelium. Ann N Y Acad Sci 1972;201:22–36.
61.Gustafsson, C, Blomback, M, Britton, M, et al. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke 1990;21:47–51.
62.Kumagai, K, Fukunami, M, Ohmori, M, et al. Increased intracardiovascular clotting in patients with chronic atrial fibrillation. J Am Coll Cardiol 1990;16:377–380.
63.Hanna, JP, Furlan, AJ. Cardiac disease and embolic sources. In Caplan, LR (ed), Brain Ischemia. London: Springer, 1995, pp 299–315.
64.Goldman, ME, Pearce, LA, Hart, RG. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation (SPAF-III) Study). J Am Soc Echocardiogr 1999;12:1080–1087.
65.Wolf, PA, Dawber, TR, Thomas, HE, Kannel, WB. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study. Neurology 1978;28:973–977.
66.Wolf, PA, Abbott, RD, Kannel, WB. Atrial fibrillation: A major contribution to stroke in the elderly. The Framingham Study. Arch Intern Med 1987;147:1561–1564.
67.Cairns, JA, Connolly, SJ. Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy. Circulation 1991;84:469–481.
68.Dunn, M, Alexander, J, DeSilva, R, Hildner, F. Antithrombotic therapy in atrial fibrillation. Chest 1989;95:S118–S127.
69.The Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: 1. Clinical features of patients at risk. Ann Intern Med 1992;116:1–5.
70.Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449–1457.
71.Caplan, LR, D’Cruz, I, Hier, DB, et al. Atrial size, atrial fibrillation, and stroke. Ann Neurol 1986;19:158–161.
72.Stroke Prevention in Atrial Fibrillation Investigators. Predictors of thromboembolism in atrial fibrillation: II. Echocardiographic features of patients at risk. Ann Intern Med 1992;116:6–12.
73.DiPasquale, G, Urbinati, S, Pinelli, G. New echocardiographic markers of embolic risk in atrial fibrillation. Cerebrovasc Dis 1995;5:315–322.
74.Vernhorst, P, Kamp, O, Visser, CA, Verheught, FWA. Left atrial appendage flow velocity assessment using transesophageal echocardiography in nonrheumatic atrial fibrillation and systemic embolism. Am J Cardiol 1993;71:192–196.
75.Garcia-Fernandez, MA, Torrecilla, EG, San Roman, D, et al. Left atrial appendage Doppler flow patterns: Implications of thrombus formation. Am Heart J 1992;124:955–965.
76.Beppu, S, Nimura, Y, Sakakibara, H. Smoke-like echo in the left atrial cavity in mitral valve disease: Its features and significance. J Am Coll Cardiol 1985;6:744–749.
77.Merino, A, Hauptman, P, Badiman, L, et al. Echocardiographic “smoke” is produced by an interaction of erythrocytes and plasma proteins modulated by shear forces. J Am Coll Cardiol 1992;20:1661–1668.
78.Black, IW, Stewart, WJ. The role of echocardiography in the evaluation of cardiac sources of embolism. Echocardiography 1993;10:429–439.
79.Chimowitz, MI, DeGeorgia, MA, Poole, RM, et al. Left atrial spontaneous echo contrast is highly associated with previous stroke in patients with atrial fibrillation or mitral stenosis. Stroke 1993;24:1015–1019.
80.Warraich, HJ, Gandhavadi, M, Manning, WJ. Mechanical discordance of the left atrium and appendage. Stroke 2014;45:1481–1484.
81.Manning, WJ, Silverman, DI, Gordon, SPF, Krumholz, HM, Douglas, PS. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med 1993;328:750–756.
82.Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med 1998;128:639–647.
83.Weigner, MJ, Thomas, LR, Patel, U, et al. Transesophageal-echocardiography-facilitated early cardioversion from atrial fibrillation: Short-term safety and impact on maintenance of sinus rhythm at 1 year. Am J Med 2001;110:694–702.
84.Klein, AL, Grimm, RA, Murray, RD, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med 2001;344:1411–1420.
85.Stoddard, MF, Dawkins, PR, Prince, CR, Ammash, NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: A transesophageal echocardiographic study. J Am Coll Cardiol 1995;25:452–459.
86.Manning, WJ, Silverman, DI, Waksmonski, CA, Oettgen, P, Douglas, PS. Prevalence of residual left atrial thrombi in patients presenting with acute thromboembolism and newly recognized atrial fibrillation. Arch Intern Med 1995;155:2193–2197.
87.Kishore, A, Vail, A, Majid, A, et al. Detection of atrial fibrillation after ischemic stroke or transient ischemic attack: A systematic review and meta-analysis. Stroke 2014;45:520–526.
88.Kamel, H. Heart-rhythm monitoring for evaluation of cryptogenic stroke. N Engl J Med 2014;370:2532–2533.
89.Sanna, T, Diener, H-C, Passman, RS, et al. for the CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 2014;370:2478–2486.
90.Gladstone, DJ, Spring, M, Dorian, P, et al. for the EMBRACE Investigators. Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 2014;370:2467–2477.
91.Hoshino, T, Nagao, T, Shiga, T, et al. Prolonged QTc interval predicts poststroke paroxysmal atrial fibrillation. Stroke 2015;46:71–76.
92.Mair, J. Biochemistry of B-type natriuretic peptide – where are we now? Clin Chem Lab Med 2008;46:1507–1514.
93.Braunwald, E. Biomarkers in heart failure. N Engl J Med 2008;358:2148–2159.
94.Patton, KK, Ellinor, PT, Heckbert, SR, et al. N-terminal pro-B-type naturetic peptide is a major predictor of the development of atrial fibrillation: The Cardiovascular Health Study. Circulation 2009;120:1768–17774.
95.Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505–1511.
96.EAFT Study Group. Silent brain infarction in nonrheumatic atrial fibrillation. Neurology 1996;46:159–165.
97.EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342:1255–1262.
98.Petersen, P, Godtfredsen, J, Boysen, G, et al. Placebo-controlled, randomized trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: The Copenhagen AFASAK Study. Lancet 1989;1:175–179.
99.Stroke Prevention in Atrial Fibrillation Investigators. The Stroke Prevention In Atrial Fibrillation Study: Final results. Circulation 1991;84:527–539.
100.Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348:633–638.
101.Stroke Prevention in Atrial Fibrillation Investigators. Prospective identification of patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. Circulation 1997;96(Suppl):1–281(abst).
102.Albers, G. Atrial fibrillation and stroke. Three new studies, three remaining questions. Arch Intern Med 1994;154:1443–1448.
103.Samsa, GP, Matchar, DB, Goldstein, LB, et al. Quality of anticoagulation management among patients with atrial fibrillation: Results of a review of medical records from two communities. Arch Intern Med 2000;160:967–973.
104.Chiquette, E, Amato, MG, Bussey, HI. Comparison of an anticoagulation clinic with usual medical care: Anticoagulation control, patient outcomes, and health care costs. Arch Intern Med 1998;158:1641–1647.
105.Kucher, N, Connolly, S, Beckman, JA, et al. International normalized ratio increase before warfarin-associated hemorrhage: Brief and subtle. Arch Intern Med 2004;164:2176–2179.
106.Rash, A, Downes, T, Portner, R, et al. A randomized controlled trial of warfarin vs. aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Ageing 2007;36:151–156.
107.Mant, J, Hobbs, FD, Fletcher, K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (The Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): A randomized controlled trial. Lancet 2007;370:493–503.
108.Di Nisio, M, Middeldorp, S, Buller, HR. Direct thrombin inhibitors. Engl J Med 2005;353:1028–1040.
109.Yeh, CH, Fredenburgh, JC, Weitz, JI. Oral direct factor Xa inhibitors. Circ Res 2012;111:1069–1078.
110.Connolly, SJ, Ezekowitz, MD, Yusuf, S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139–1151.
111.Connolly, SJ, Eikelboom, J, Joyner, C, et al. Apixaban in patients with atrial fibrillation. N Engl J Med 2011;364:806–817.
112.Granger, CB, Alexander, JH, McMurray, JJ, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011;365:981–992.
113.Patel, MR, Mahaffey, KW, Garg, J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011;365:883–891.
114.Giugliano, RP, Ruff, CT, Braunwald, E, et al. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2013;369:2093–2104.
115.Cameron, C, Coyle, D, Richter, D, et al. Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation. BMJ Open 2014;4:e004301.
116.Sherman, DG. Stroke prevention in atrial fibrillation. Pharmacological rate vs. rhythm control. Stroke 2007;38(part 2):615–617.
117.Roy, D, Talajic, M, Nattel, S, et al. for the Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008;358:2667–2677.
118.Gillinov, AM. Advances in surgical treatment of atrial fibrillation. Stroke 2007:38 (part 2): 618–623.
119.Tung, R, Buch, E, Shivkumar, K. Catheter ablation of atrial fibrillation. Circulation 2012;126:223–229.
120.Reddy, VY, Doshi, SK, Sievert, H, et al. on behalf of the PROTECT AF Investigators. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation. Circulation 2013;127:720–729.
121.Swaans, MJ, Post, MC, Rensing, BJWM, Boersma, LVA. Ablation for atrial fibrillation in combination with left atrial appendage closure: First results of a feasibility study. J Am Heart Assoc 2012;1:e002212.
122.Onalan, O, Crystal, E. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. Stroke 2007;38 (part 2):624–630.
123.Syed, TM, Halperin, JL. Left atrial appendage closure for stroke prevention in atrial fibrillation: State of the art and current challenges. Nat Clin Pract Neurol 2007;4:428–435.
124.Maisel, WH. Left atrial appendage occlusion – closure or just the beginning. N Engl J Med 2009;360:2601–2603.
125.Rubenstein, JJ, Schulman, CL, Yurchak, PM, et al. Clinical spectrum of the sick sinus syndrome. Circulation 1972;46:5–13.
126.Fairfax, AJ, Lambert, CD, Leatham, A. Systemic embolism in chronic sinoatrial disorder. N Engl J Med 1976;295:190–192.
127.Lown, B. Electrical reversion of cardiac arrhythmias. Br Heart J 1967;29:469–489.
128.Orencia, AJ, Hammill, SC, Whisnant, JP. Sinus node dysfunction and ischemic stroke. Heart Dis Stroke 1994;3:91–94.
129.Phillips, SJ, Whisnant, JP, O’Fallon, WM, Frye, RL. Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc 1990;65:344–359.
130.Radford, DJ, Julian, DG. Sick sinus syndrome. Experience of a cardiac pacemaker clinic. BMJ 1974;3:504–507.
131.Rosenqvist, M, Vallin, H, Edhag, O. Clinical and electrophysiologic course of sinus node disease: Five-year follow-up study. Am Heart J 1985;109:513–522.
132.Bathen, J, Sparr, S, Rokseth, R. Embolism in sinoatrial disease. Acta Med Scand 1978;203:7–11.
133.Cerebral Embolism Task Force. Cardiogenic brain embolism. Arch Neurol 1986;43:71–84.
134.Stein, PD, Sabbah, HN, Pitha, JV. Continuing disease process of calcific aortic stenosis. Am J Cardiol 1977;39:159–163.
135.Casella, L, Abelmann, WH, Ellis, LB. Patients with mitral stenosis and systemic emboli. Arch Int Med 1964;114:773–781.
136.Weiss, S, Davis, D. Rheumatic heart disease: III. Embolic manifestations. Am Heart J 1933;9:45–52
137.Wallach, JB, Lukash, L, Angrist, AA. An interpretation of the incidence of mitral thrombi in the left auricle and appendage with particular reference to mitral commissurotomy. Am Heart J 1953;45:252–254.
138.Bannister, RB. Risk of deferring valvotomy in patients with moderate mitral stenosis. Lancet 1960;2:329–332.
139.Szekely, P. Systemic embolism and anticoagulant prophylaxis in rheumatic heart disease. BMJ 1964;1:1209–1212.
140.Keen, G, Leveaux, VM. Prognosis of cerebral embolism in rheumatic heart disease. BMJ 1958;2:91–92.
141.Coulshed, N, Epstein, EJ, McKendrick, CS, et al. Systemic embolism in mitral valve disease. BMJ 1970;32:26–34.
142.Daley, R, Mattingly, TW, Holt, CL, et al. Systemic arterial embolism in rheumatic heart disease. Am Heart J 1951;42:566–581.
143.Fleming, HA, Bailey, SM. Mitral valve disease, systemic embolism and anticoagulants. Postgrad Med J 1971;47:599–604.
144.Carabello, BA, Crawford, FA. Valvular heart disease. N Engl J Med 1997;337:32–41.
145.Soulie, P, Caramanian, M, Soulie, J, Bader, JL, Colcher, E. Les embolies calcaires des atteintes orificielles calcifees du coeur gauche. Arch Mal Coeur Vaiss 1969;12:1657–1684.
146.Holley, KE, Bahn, RC, McGoon, DC, Mankin, HT. Spontaneous calcific embolization associated with calcific aortic stenosis. Circulation 1963;27:197–202.
147.Klues, HG, Maron, BJ, Dollar, AL, Roberts, WC. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation 1992;85:1651–1660.
148.Hardarson, T, De la Calzada, CS, Curiel, R, Goodwin, JF. Prognosis and mortality of hypertrophic obstructive cardiomyopathy. Lancet 1973;1462–1467.
149.Glancy, DL, O’Brien, KP, Gold, HK, Epstein, SE. Atrial fibrillation in patients with idiopathic hypertrophic subaortic stenosis. Brit Heart J 1970;32:652–659.
150.Tajik, AJ, Giuliani, ER, Frye, RL, et al. Mitral valve and/or annulus calcification assoiated with hypertrophic subaortic stenosis (IHSS). Circulation 1972;16(Suppl II):228.
151.Barlow, JB, Bosman, CK. Aneurysmal protrusion of posterior leaflets of the mitral valve. An auscultatory-electrocardiographic syndrome. Am Heart J 1966;71:166–178.
152.Lauzier, S, Barnett, HJM. Cerebral ischemia with mitral valve prolapse and mitral annular calcification. In Furlan, AJ (ed), The Heart and Stroke: Exploring Mutual Cerebrovascular and Cardiovascular Issues. London: Springer, 1987, pp 63–100.
153.Markiewicz, W, Stoner, J, London, E, et al. Mitral valve prolapse in one hundred presumably healthy young females. Circulation 1976;53:464–473.
154.Cheitlin, MD, Byrd, RC. Prolapsed mitral valve: The commonest valve disease? Curr Probl Cardiol 1984;8:3–53.
155.Ranganatham, N, Silver, MD, Robinson, T, et al. Angiographic–morphological correlation in patients with severe mitral regurgitation due to prolapse of the posterior mitral valve leaflet. Circulation 1973;48:514–518.
156.Kostuk, WJ, Boughner, DR, Barnett, HJM, Silver, MD. Strokes: A complication of mitral-leaflet prolapse? Lancet 1977;2:313–316.
157.Marks, AR, Choong, CY, Sanfillipo, AJ, et al. Identification of high-risk and low-risk subgroups of patients with mitral-valve prolapse. N Engl J Med 1989;320:1031–1036.
158.Nishimura, RA, McGoon, MD, Shub, C, et al. Echocardiographically documented mitral-valve prolapse: Long term follow-up of 237 patients. N Engl J Med 1985;313:1305–1309.
159.Barnett, HJM. Transient cerebral ischemia: Pathogenesis, prognosis, and management. Ann Royal Coll Phys Surg Can 1974;7:153–173.
160.Barnett, HJM, Jones, MW, Boughner, DR, Kostuk, WJ. Cerebral ischemic events associated with prolapsing mitral valve. Arch Neurol 1976;33:777–782.
161.Barnett, HJM, Boughner, DR, Taylor, DW, et al. Further evidence relating mitral-valve prolapse to cerebral ischemic events. N Engl J Med 1980;302:139–144.
162.Aronow, WS, Koenigsberg, M, Kronzon, I, Gutstein, H. Association of mitral annular calcium with new thromboembolic stroke and cardiac events at 39-month follow-up in elderly patients. Am J Cardiol 1990;65:1511–1512.
163.Benjamin, EJ, Plehn, JF, D’Agostino, RB, et al. Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med 1992;327:374–379.
164.Korn, D, DeSanctis, R, Sell, S. Massive calcification of the mitral valve, a clinicopathological study of fourteen cases. N Engl J Med 1962;267:900–909.
165.DeBono, D, Warlow, C. Mitral annulus calcification and cerebral or retinal ischemia. Lancet 1979;2:383–385.
166.Benjamin, EJ, Plehn, JF, D’Agostino, RB, et al. Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med 1992;327:374–379.
167.Kizer, J, Wiebers, DO, Whisnant, JP, et al. Mitral annular calcification, aortic valve sclerosis, and incident stroke in adults free of clinical cardiovasacular disease. The Strong Heart Study. Stroke 2005;36:2533–2537.
168.Pomerance, A. Pathological and clinical study of calcification of the mitral valve ring. J Clin Pathol 1970;23:354–361.
169.Stein, JH, Soble, JS. Thrombus associated with mitral valve calcification. A possible mechanism for embolic stroke. Stroke 1995;26:1697–1699.
170.Barnett, HJM. Stroke by cause. Some common, some exotic, some controversial. Stroke 2005;36:2523–2525.
171.Adler, Y, Shohat-Zabarski, R, Vaturi, M, et al. Association between mitral annular calcium and aortic atheroma as detected by transesophageal echocardiographic study. Am J Cardiol 1998;81:784–786.
172.Vongpatanasin, W, Hillis, D, Lange, RA. Prosthetic heart valves. N Engl J Med 1996;335:407–416.
173.Edmunds, LH Jr. Thromboembolic complications of current cardiac valvular prostheses. Ann Thor Surg 1982;34:96–106.
174.Metzdorff, MT, Grunkemeier, GL, Pinson, CW, Starr, A. Thrombosis of mechanical cardiac valves: A qualitative comparison of the silastic ball valve and the tilting disc valve. J Am Coll Cardiol 1984;4:50–53.
175.Harker, LA, Slichter, SL. Studies of platelet and fibrinogen kinetics in patients with prosthetic heart valves. N Engl J Med 1970;283:1302–1305.
176.Silber, H, Khan, SS, Matloff, JM, et al. The St. Jude valve: Thrombolysis as the first line of therapy for cardiac valve thrombosis. Circulation 1993;87:30–37.
177.Vitale, N, Renzulli, A, Cerasuolo, F, et al. Prosthetic valve obstruction: Thrombolysis versus operation. Ann Thorac Surg 1994;57:365–370.
178.Cannegieter, SC, Rosendaal, FR, Briet, E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation 1994;89:635–641.
179.Cohn, LH, Mudge, GH, Pratter, F, Collins, JJ Jr. Five to eight-year follow-up of patients undergoing porcine heart-valve replacement. N Engl J Med 1981;304:258–262.
180.Osler, W. Gulstonian lectures on malignant endocarditis. Lancet 1885;1:459–465.
181.Jones, HR, Siekert, RG, Geraci, J. Neurologic manifestations of bacterial endocarditis. Ann Intern Med 1969;71:21–28.
182.Salgado, AV, Furlan, AJ, Keys, TF, et al. Neurologic complications of endocarditis: A 12-year experience. Neurology 1989;39:173–178.
183.Hart, RG, Foster, JW, Luther, MF, Kanter, MC. Stroke in infective endocarditis. Stroke 1990;21:695–700.
184.Kanter, MC, Hart, RG. Neurologic complications of infective endocarditis. Neurology 1991;41:1015–1020.
185.Keyser, DL, Biller, J, Coffman, TT, Adams, HP. Neurologic complications of late prosthetic valve endocarditis. Stroke 1990;21:472–475.
186.Matsushita, K, Kuriyama, Y, Sawada, T, et al. Hemorrhagic and ischemic cerebrovascular complications of active infective endocarditis of native valve. Eur Neurol 1993;33:267–274.
187.Pruitt, AA, Rubin, RH, Karchmer, AW, Duncan, GW. Neurological complications of bacterial endocarditis. Medicine 1978;57:329–43.
188.Steckelberg, JM, Murphy, JG, Ballard, D, et al. Emboli in infective endocarditis: The prognostic value of echocardiography. Ann Intern Med 1991;114:635–640.
189.Tunkel, AR, Mandell, GL. Infecting microorganisms. In Kay, D, (ed.), Infective Endocarditis. New York: Raven Press, 1992, pp 85–97.
190.Garvey, GJ, Neu, HC. Infective endocarditis – an evolving disease. A review of endocarditis at the Columbia-Presbyterian Medical Center, 1968–1973. Medicine 1978;57:105–127.
191.Jaffe, WM, Morgan, DE, Pearlman, AS, Otto, CM. Infective endocarditis, 1983–1988: Echocardiographic findings and factors influencing morbidity and mortality. J Am Coll Cardol 1990:15:1227–1233.
192.Rohmann, S, Erbel, R, Gorge, G, et al. Clinical relevance of vegetation localization by transesophageal echocardiography in infective endocarditis. Eur Heart J 1992;12:446–452.
193.Shively, BK, Gurule, FT, Roldan, CA, Leggett, JH, Schiller, NB. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J Am Coll Cardiol 1991;18:391–397.
194.Sanfilippo, AJ, Picard, MH, Newell, JB, et al. Echocardiographic assessment of patients with infectious endocarditis: Prediction of risk for complications. J Am Coll Cardiol 1991;18:1191–1199.
195.Hart, RG, Kagan-Hallet, K, Joerns, S. Mechanisms of intracranial hemorrhage in infective endocarditis. Stroke 1987;18:1048–1056.
196.Masuda, J, Yutani, C, Waki, R, et al. Histopathological analysis of the mechanisms of intracranial hemorrhage complicating infective endocarditis. Stroke 1992;23:843–850.
197.Klein, I, Iung, B, Wolff, M, et al. Silent T2* cerebral microbleeds. A potential new imaging clue in infective endocarditis. Neurology 2007;68:2043.
198.Nandigam, K. Silent T2* cerebral microbleeds: A potential new imaging clue in infective endocarditis. Neurology 2008;70:323–324.
199.Morawetz, RB, Karp, RB. Evolution and resolution of intracranial bacterial (mycotic) aneurysms. Neurosurgery 1984;15:43–49.
200.Moskowitz, MA, Rosenbaum, AE, Tyler, HR. Angiographically monitored resolution of cerebral mycotic aneurysms. Neurology 1974;24:1103–1108.
201.Bingham, WF. Treatment of mycotic intracranial aneurysms. J Neurosurg 1977;46:428–437.
202.Bertorini, TE, Laster, RE, Thompson, BF, Gelfand, M. Magnetic resonance imaging of the brain in bacterial endocarditis. Arch Intern Med 1989;149:815–817.
203.Libman, E, Sacks, B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 1924;33:701–737.
204.Klemperer, P, Pollack, AD, Baehr, G. Pathology of disseminated lupus erythematosus. Arch Pathol 1941;32:569–631.
205.Baehr, G, Klemperer, P, Schifrin, A. A diffuse disease of the peripheral circulation usually associated with lupus erythematosus and endocarditis. Trans Assoc Am Physicians 1935;50:139–155.
206.Gross, L. The cardiac lesions in Libman–Sacks disease, with a consideration of its relationship to acute diffuse lupus erythematosus. Am J Pathol 1940;16:375–407.
207.Roldan, CA, Shively, B, Crawford, MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996;335:1424–1430.
208.Moyssakis, I, Tektonidou, MG, Vassilios, V, et al. Libman–Sacks endocarditis in systemic lupus erythematosus: Prevalence, associations, and evolution. Am J Med 2007;120:636–642.
209.Barbut, D, Borer, J, Gharavi, A, et al. Prevalence of anticardiolipin antibody in isolated mitral or aortic regurgitation, or both, and possible relation to cerebral ischemic events. Am J Cardiol 1992;70:901–905.
210.Barbut, D, Borer, J, Wallerson, D, et al. Anticardiolipin antibody and stroke: Possible relation of valvular heart disease and embolic events. Cardiology 1991;79:99–109.
211.Antiphospholipid Antibodies in Stroke Study Group. Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. Stroke 1990;21:1268–1273.
212.Amico, L, Caplan, LR, Thomas, C. Cerebrovascular complications of mucinous cancer. Neurology 1989;39:522–526.
213.Reagan, TJ, Okazaki, H. The thrombotic syndrome associated with carcinoma. Arch Neurol 1974;31:390–395.
214.Edoute, Y, Haim, N, Rinkevich, D, Brenner, B, Reisner, SA. Cardiac valvular vegetations in cancer patients: A prospective echocardiographic study of 200 patients. Am J Med 1997;102:252–258.
215.Connolly, HM, Crary, JL, McGoon, MD, et al. Valvular heart disease associated with Fenflurmine-phentermine. N Engl J Med 1997;337:581–588.
216.Yamamoto, M, Uesugi, T, Nakayama, T. Dopamine agonists and cardiac valvulopathy in Parkinson’s disease: A case control study. Neurology 2006;67:1225–1229.
217.Lambl, VA. Papillare exkreszenzen an der semilunar-klappe der aorta. Wien Med Wochenscshr 1856;6:244–247.
218.Magarey, FR. On the mode of formation of Lambl’s excrescences and their relation to chronic thickening of the mitral valve. J Pathol Bacteriol 1949;61:203–208.
219.Roldan, CA, Shively, BK, Crawford, MH. Valve excrescences: Prevalence, evolution and risk for embolism. J Am Coll Cardiol 1997;30:1308–1314.
220.Freedberg, RS, Goodkin, GM, Perez, JL, et al. Valve strands are strongly associated with systemic embolization: A transesophageal echocardiographic study. J Am Coll Cardiol 1995;26:1709–1712.
221.Roberts, JK, Omarali, I, Di Tullio, MR, et al. Valvular strands and cerebral ischemia. Effect of demographics and strand characteristics. Stroke 1997;28:2185–2188.
222.Cohen, A, Tzourio, C, Chauvel, C, et al. Mitral valve strands and the risk of ischemic stroke in elderly patients. Stroke 1997;28:1574–1578.
223.Lee, RJ, Bartzokis, T, Yeoh, TK, et al. Enhanced detection of intracardiac sources of cerebral emboli by transesophageal echocardiography. Stroke 1991;22:734–739.
224.Nighoghossian, N, Derex, L, Loire, R, et al. Giant Lambl excrescences. An unusual source of cerebral embolism. Arch Neurol 1997;54:41–44.
225.Vaitkus, PT, Berlin, JA, Schwartz, JS, Barnathan, ES. Stroke complicating acute myocardial infarction: A meta-analysis of risk modification by anticoagulation and thrombolytic therapy. Arch Intern Med 1992;152:2020–2024.
226.Konrad, MS, Coffey, CE, Coffey, KS, et al. Myocardial infarction and stroke. Neurology 1984;34:1403–1409.
227.Chiarella, F, Santoro, E, Domenicucci, S, et al. on behalf of the GISSI-3 Investigators. Predischarge two-dimensional echocardiographic evaluation of left ventricular thrombosis after acute myocardial infarction in the GISSI-3 study. Am J Cardiol 1998;81:822–827.
228.Meltzer, RS, Visser, CA, Fuster, V. Intracardiac thrombi and systemic embolization. Ann Intern Med 1986;104:689–698.
229.Visser, CA, Kan, G, Meltzer, RS, et al. Embolic potential of left ventricular thrombi after myocardial infarction: A two-dimensional echocardiographic study of 119 patients. J Am Coll Cardiol 1985;5:1276–1280.
230.Kouvaras, G, Chronopoulas, G, Soufras, G, et al. The effects of long term antithrombotic treatment on left ventricular thrombi in patients after an acute myocardial infarction. Am Heart J 1990;119:73–78.
231.Asinger, RW, Mikell, FL, Elsperger, J, Hodges, M. Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography. N Engl J Med 1981;305:297–302.
232.Nihoyannopoulos, P, Smith, GC, Maseri, A, Foale, RA. The natural history of left ventricular thrombus in myocardial infarction: A rationale in support of masterly inactivity. J Am Coll Cardiol 1989;14:903–911.
233.Greaves, SC, Zhi, G, Lee, RT, et al. Incidence and natural history of left ventricular thrombus following anterior wall acute myocardial infarction. Am J Cardiol 1997;80:442–448.
234.Keren, A, Goldberg, S, Gottlieb, S, et al. Natural history of left ventricular thrombi: Their appearance and resolution in the posthospitalization period of acute myocardial infarction. J Am Coll Cardiol 1990;15:790–800.
235.Domenicucci, S, Chiarella, F, Bellotti, P, et al. Long-term prospective assessment of left ventricular thrombus in anterior wall acute myocardial infarction and implications for a rational approach to embolic risk. Am J Cardiol 1999;83:519–524.
236.Lapeyre, AC III, Steele, PM, Kazmier, FJ, et al. Systemic embolism in chronic left ventricular aneurysm: Incidence and the role of anticoagulation. J Am Coll Cardiol 1985;6:534–538.
237.Anticoagulants in acute myocardial infarction: Results of a cooperative clinical trial. JAMA 1973;225:724–729.
238.Faxon, DP, Ryan, TJ, Davis, KB, et al. Prognostic significance of angiographically documented left ventricular aneurysm from the coronary artery surgery study (CASS). Am J Cardiol 1982;50:157–164.
239.Reeder, GS, Lengyei, M, Tajik, AJ, et al. Mural thrombus in left ventricular aneurysm. Incidence, role of angiography, and relation between anticoagulation and embolism. Mayo Clin Proc 1981;56:77–81.
240.Loh, E, Sutton, M, Wun, C-C, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 1997;336:251–257.
241.Stratton, JR, Lighty, GW, Pearlman, AS, Ritchie, JL. Detection of left ventricular thrombus by two-dimensional echocardiography: Sensitivity, specificity, and causes of uncertainty. Circulation 1982;66:156–166.
242.Ports, TA, Cogan, J, Schiller, NB, Rapaport, E. Echocardiography of left ventricular masses. Circulation 1978;58:528–536.
243.Chen, C, Koschyk, D, Hamm, C, et al. Usefulness of transesophageal echocardiography in identifying small left ventricular apical thrombus. J Am Coll Cardiol 1993;21:208–215.
244.Oppenheimer, SM, Lima, J. Neurology and the heart. J Neurol Neurosurg Psychiatry 1998;64:289–297.
245.Wong, C, Marwick, TH. Obesity cardiomyopathy: Diagnosis and therapeutic implications. Nature Clin Practice Cardiovasc Med. 2007;4:480–489.
246.Grabowski, A, Kilian, J, Strank, C, Cieslinski, G, Meyding-Lamade, U. Takotsubo cardiomyopathy – a rare cause of cardioembolic stroke. Cerebrovasc Dis 2007;24:146–148.
247.Ziegelstein, RC. Acute emotional stress and cardiac arrhythmias. JAMA 2007;298:324–329.
248.Wold, LE, Lie, JT. Cardiac myxomas: A clinicopathologic profile. Am J Pathol 1980;101:219–240.
249.Reynen, K. Cardiac myxomas. N Engl J Med 1995;333:1610–1617.
250.Blondeau, P. Primary cardiac tumors: French study of 533 cases. Thorac Cardiovasc Surg 1990;38 (Suppl 2):192–195.
251.Lee, VH, Connolly, HM, Brown, RD Jr. Central nervous system manifestations of cardiac myxoma. Arch Neurol 2007;64:1115–1120.
252.Sandok, BA, von Estorff, I, Giuliani, ER. Subsequent neurological events in patients with atrial myxoma. Ann Neurol 1980;8:305–307.
253.Edwards, FH, Hale, D, Cohen, A, et al. Primary cardiac valve tumors. Ann Thorac Surg 1991;52:1127–1131.
254.Giannesini, C, Kubis, N, N’Guyen, A, et al. Cardiac papillary fibroelastoma: A rare cause of ischemic stroke in the young. Cerebrovasc Dis 1999;9:45–49.
255.Brown, RD, Khandheria, BK, Edwards, WD. Cardiac papillary fibroelastoma: A treatable cause of transient ischemic attack and ischemic stroke detected by transesophageal echocardiography. Mayo Clin Proc 1995;70:863–868.
256.Klarich, KW, Enriquez-Sarano, M, Gura, GM, et al. Papillary fibroelastoma: Echocardiographic characteristics for diagnosis and pathologic correlation. J Am Coll Cardiol 1997;30:784–90.
257.Gagliardi, R, Franken, R, Protti, G. Cardiac papillary fibroelastoma and stroke in a young man – etiology and treatment. Cerebrovasc Dis 2008;185–187.
258.Azarbal, B, Tobis, J. Interatrial communications, stroke, and migraine headache. Appl Neurol 2005;1:22–36.
259.Hagen, PT, Scholz, DG, Edwards, WD. Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17–20.
260.Lechat, PH, Mas, JL, Lascault, G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148–1152.
261.Di Tullio, M, Sacco, RL, Gopal, A, et al. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med 1992;117:461–465.
262.Petty, GW, Khanderia, BK, Chu, C-P, et al. Patent foramen ovale in patients with cerebral infarction. A transesophageal echocardiographic study. Arch Neurol 1997;54:819–822.
263.Gautier, JC, Durr, A, Koussa, S, et al. Paradoxical cerebral embolism with a patent foramen ovale. A report of 29 patients. Cerebrovasc Dis 1991;1:193–202.
264.Venketasubramanian, N, Sacco, RL, Di Tullio, M, et al. Vascular distribution of paradoxical emboli by transcranial Doppler. Neurology 1993;43:1533–1535.
265.Kim, BJ, Kim, N-Y, Kang, D-W, Kim, JS, Kwon, SU. Provoked right-to-left shunt in patent foramen ovale associates with ischemic stroke in posterior circulation. Stroke 2014;45:3707–3710.
266.Konstantinides, S, Kasper, W, Geibel, A, et al. Detection of left-to-right shunt in atrial septal defect by negative contrast echocardiography: A comparison of transthoracic and transesophageal approach. Am Heart J 1993;126:909–917.
267.Hamann, GF, Schatzer-Klotz, D, Frohlig, G, et al. Femoral injection of echo contrast medium may increase the sensitivity of testing for a patent foramen ovale. Neurology 1998;50:1423–1428.
268.Hausmann, D, Mügge, A, Daniel, WG. Identification of patent foramen ovale permitting paradoxic embolism. J Am Coll Cardiol 1995;26:1030–1038.
269.Homma, S, Tullio, MR, Sacco, RL, et al. Characteristics of patent foramen ovale associated with cryptogenic stroke: A biplane transesophageal echocardiographic study. Stroke 1994;25:582–586.
270.Chimowitz, MI, Nemec, JJ, Marwick, TH, et al. Transcranial Doppler ultrasound identifies patients with right-to-left cardiac or pulmonary shunts. Neurology 1991;41:1902–1904.
271.Albert, A, Muller, HR, Hetzel, A. Optimized transcranial Doppler technique for the diagnosis of cardiac right-to-left shunts. J Neuroimaging 1997;7:159–163.
272.Di Tullio, M, Sacco, RL, Venketasubramanian, N, et al. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 1993;24:1020–1024.
273.Mohrs, OK, Petersen, SE, Erkapic, D, et al. Diagnosis of patent foramen ovale using contrast-enhanced dynamic MRI: A pilot study. AJR Am J Roetgenol 2005;184:234–240.
274.Ilercil, A, Meisner, JS, Vijayaraman, P, et al. Clinical significance of fossa ovalis membrane aneurysm in adults with cardioembolic cerebral ischemia. Am J Cardiol 1997;80:96–99.
275.Belkin, RN, Hurwitz, BJ, Kislo, J. Atrial septal aneurysm: Association with cerebrovascular and peripheral embolic events. Stroke 1987;18:856–862.
276.Schneider, B, Hanrath, P, Vogel, P, Meinertz, T. Improved morphologic characterization of atrial septal aneurysm by transesophageal echocardiography: Relation to cerebrovascular events. J Am Coll Cardiol 1990;16:1000–1009.
277.Burger, AJ, Sherman, HB, Charlamb, MJ. Low incidence of embolic strokes with atrial septal aneurysms: A prospective, long-term study. Am Heart J 2000;139:149–152.
278.Agmon, Y, Khandheria, BK, Meissner, I, et al. Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation 1999;99:1942–1944.
279.Zabalgoitia-Reyes, M, Herrera, C, Gandhi, DK, et al. A possible mechanism for neurologic ischemic events in patients with atrial septal aneurysm. Am J Cardiol 1990;66:761–764.
280.Berthet, K, Lavergne, T, Cohen, A, et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 2000;31:398–403.
281.Silver, MD, Dorsey, JS. Aneurysms of the septum primum in adults. Arch Pathol Lab Med 1978;102:62–65.
282.Cabanes, L, Mas, JL, Cohen, A, et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 1993;24:1865–1873.
283.Hanna, JP, Sun, JP, Furlan, AJ, et al. Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention. Stroke 1994;25:782–786.
284.Ay, H, Buonanno, FS, Abraham, S, et al. An electrocardiographic criterion for diagnosis of patent foramen ovale associated with ischemic stroke. Stroke 1998;29:1393–1397.
285.Bogousslavsky, J, Garazi, S, Jeanrenaud, X, et al. Stroke recurrence in patients with patent foramen ovale: The Lausanne study. Neurology 1996;46:1301–1305.
286.French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Recurrent cerebrovascular events in patients with patent foramen ovale or atrial septal aneurysms and cryptogenic stroke or TIA. Am Heart J 1995;130:1083–1088.
287.Devuyst, G, Bogousslavsky, J, Ruchat, P, et al. Prognosis after stroke followed by surgical closure of patent foramen ovale: A prospective follow-up study with brain MRI and simultaneous transesophageal and transcranial Doppler ultrasound. Neurology 1996;47:1162–1166.
288.Kim, D, Saver, JL. Patent foramen ovale and stroke: What we do and don’t know. Rev Neurol Dis 2005;2:1–7.
289.Bridges, ND, Hellensbrand, W, Catson, L, et al. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation 1992;86:1902–1908.
290.Li, Y, Zhou, K, Hua, Y, et al. Amplatzer occluder versus Cardioseal/Starflex occluder: A meta-analysis of the efficacy and safety of transcatheter occlusion for patent foramen ovale and atrial septal defect. Cardiol Young 2013;23:582–596.
291.Carroll, JD, Saver, JL, Thaler, DE, et al. for the RESPECT Investigators. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 2013;368:1092–1100.
292.Meier, B, Kalesan, B, Mattle, HP, et al. for the PC Trial Investigators. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 2013;368:1083–1091.
293.Furlan, AJ, Reisman, M, Joseph Massaro, J, et al. for the CLOSURE I Investigators. Closure or medical therapy for cryptogenic stroke with patent foramen ovale. N Engl J Med 2012;366:991–999.
294.Kent, DM, Ruthazer, R, Weimar, C, et al. An index to identify stroke-related vs. incidental patent foramen ovale in cryptogenic stroke. Neurology 2013;81:619–625.
295.Thaler, DE, Ruthazer, R, Weimar, C, et al. Recurrent stroke predictors differ in medically treated patients with pathogenic vs. other PFOs. Neurology 2014;83:221–226.
296.Bogousslavsky, J, Cachin, C, Regli, F, et al. Cardiac sources of embolism and cerebral infarction. Clinical consequences and vascular concomitants. Neurology 1991;41:855–859.
297.Tunick, PA, Kronzon, I. Protruding atherosclerotic plaque in the aortic arch of patients with systemic embolization: A new finding seen by transesophageal echocardiography. Am Heart J 1990;120:658–660.
298.Tunick, PA, Culliford, AT, Lamparello, PJ, Kronzon, I. Atheromatosis of the aortic arch as an occult source of multiple systemic emboli. Ann Intern Med 1991;114:391–392.
299.Tunick, PA, Perez, JL, Kronzon, I. Protruding atheromas in the thoracic aorta and systemic embolization. Ann Intern Med 1991;115:423–427.
300.Amarenco, P, Duyckaerts, C, Tzourio, C, et al. The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med 1992;326:221–225.
301.Amarenco, P, Cohen, A, Baudrimont, M, Bousser, M-G. Transesophageal echocardiographic detection of aortic arch disease in patients with cerebral infarction. Stroke 1992;23:1005–1009.
302.Tobler, HG, Edwards, JE. Frequency and location of atherosclerotic plaques in the ascending aorta. J Thor Cardiovasc Surg 1988;96:304–306.
303.Bruns, JL, Segel, DP, Adler, S. Control of cholesterol embolization by discontinuation of anticoagulant therapy. Am J Med Sci 1978;275:105–108.
304.French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 1996;334:1216–1221.
305.Mitusch, R, Doherty, C, Wucherpfennig, H, et al. Vascular events during follow-up in patients with aortic arch atherosclerosis. Stroke 1997;28:36–39.
306.Amarenco, P, Cohen, A. Update on imaging aortic atherosclerosis. Adv Neurol 2003;92:75–89.
307.Vaduganathan, V, Ewton, A, Nagueh, SF, et al. Pathologic correlates of aortic plaques, thrombi and mobile “aortic debris” imaged in vivo with transesophageal echocardiography J Am Coll Cardiol 1997;30:357–363.
308.Weinberger, J, Azhar, S, Danisi, F, Hayes, R, Goldman, M. A new noninvasive technique for imaging atherosclerotic plaque in the aortic arch of stroke patients by transcutaneous real-time B-mode ultrasonography. Stroke 1998;29:673–676.
309.Schwammenthal, A, Schwammenthal, Y, Tanne, D, et al. Transcutaneous detection of aortic arch atheromas by suprasternal harmonic imaging. J Am Coll Cardiol 2002;39:1127–1132.
310.Kutz, SM, Lee, VS, Tunick, PA, et al. Atheromas of the thoracic aorta: A comparison of transesophageal echocardiography and breath-hold gadolinium enhanced 3-dimensional magnetic resonance angiography. J Am Soc Echocardiogr 1999;12:853–858.
311.Barkhausen, J, Ebert, W, Heyer, C, Debatin, JF, Weinmann, H-J. Detection of atherosclerotic plaque with gadofluorine-enhanced magnetic resonance imaging. Circulation 2003;108:605–609.
312.Harloff, A, Dudler, P, Frydrychowicz, A, et al. Reliability of aortic MRI at 3 Tesla in patients with cryptogenic stroke. J Neurol Neurosurg Psychiatry 2007;79:540–546.
313.Chatzikonstantinou, A, Krissak, R, Fluchter, S, et al. CT angiography of the aorta is superior to transesophageal echocardiography for determining stroke subtypes in patients with cryptogenic stroke. Cerebrovasc Dis 2012;33:322–328.
314.Wehrum, T, Kams, M, Strecker, C, et al. Prevalence of potential retrograde embolization pathways in the proximal descending aorta in stroke patients. Cerebrovas Dis 2014;38:410–417.
315.Yamashiro, K, Funabe, S, Tanaka, R, et al. Primary aortic sarcoma. Neurology 2015;84:755–756.
316.Blackshear, JL, Jahangir, A, Oldenberg, WA, Safford, RE. Digital embolization from plaque-related thrombus in the thoracic aorta: Identification with transesophageal echocardiography and resolution with warfarin therapy. Mayo Clin Proc 1993;68:268–272.
317.Freedberg, RS, Tunick, PA. Culliform, AT, Tatelbaum, RJ, Kronzon, I. Disappearance of a large intraaortic mass in a patient with prior systemic embolization. Am Heart J 1993;125:1445–1447.
318.Fine, MJ, Kapoor, W, Falanga, V. Cholesterol crystal embolization: A review of 221 cases in the English literature. Angiology 1987;38:769–784.
319.Hausmann, D, Gulba, D, Bargheer, , et al. Successful thrombolysis of an aortic-arch thrombus in a patient after mesenteric embolism. N Engl J Med 1992;327:500–501.
320.Belden, JR, Caplan, LR, Bojar, RM, Payne, DD, Blachman, P. Treatment of multiple cerebral emboli from an ulcerated, thrombogenic ascending aorta with aortectomy and graft replacement. Neurology 1997;49:621–622.
321.Amarenco, P, Davis, S, Jones, EF, et al. for the Aortic Arch Related Cerebral Hazard Trial Investigators. Clopidogrel plus aspirin versus warfarin in patients with stroke and aortic arch plaques. Stroke 2014;45:1248–1257.
322.Slogoff, S, Girgis, KZ, Keats, AS. Etiologic factors in neuropsychiatric complications associated with cardiopulmonary bypass. Anesth Analg 1982;61:903–911.
323.Gilman, S. Neurological complications of open heart surgery. Ann Neurol 1990;28:475–476.
324.Shaw, PJ, Bates, D, Cartledge, NEF. Early neurological complications of coronary artery bypass surgery. BMJ 1985;391:1384–1387.
325.Breuer, AC, Furlan, AJ, Hanson, MR, et al. Central nervous system complications of coronary artery bypass graft surgery: Prospective analysis of 421 patients. Stroke 1983;14:682–687.
326.Coffey, CE, Massey, EW, Roberts, KB, et al. Natural history of cerebral complication of coronary artery bypass graft surgery. Neurology 1983;33:1416–1421.
327.Feeney, DM, Gonzalez, A, Law, WA. Amphetamine, haloperidol and experience interact to affect the rate of recovery after motor cortex injury. Science 1982;217:855–857.
328.Houda, DA, Feeney, DM. Haloperidol blocks amphetamine induced recovery of binocular depth perception of the bilateral visual cortex abilities in the cat. Proc West Pharmacol Soc 1985;28:209–211.
329.Sila, C. Neuroimaging of cerebral infarction associated with coronary revascularization. AJNR Am J Neuroradiol 1991;12:817–818.
330.Moody, DM, Bell, MA, Challa, VR, et al. Brain microemboli during cardiac surgery or aortography. Ann Neurol 1990;28:477–486.
331.Pugsley, W, Klinger, L, Paschalis, C, et al. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke 1994;25:1393–1399.
332.Barbut, D, Caplan, LR. Brain complications of cardiac surgery. Curr Probl Cardiol 1997;22:445–476.
333.Barbut, D, Lo, Y, Gold, JP, et al. Impact of embolization during coronary artery bypass grafting on outcome and length of stay. Ann Thor Surg 1997;63:998–1002.
334.Clark, RE, Brillman, J, Davis, DA, et al. Microemboli during coronary artery bypass grafting: Genesis and effect on outcome. J Thorac Cardiovasc Surg 1995;25:1393–1399.
335.Tufo, HM, Ostfeld, AM, Shekelle, R. Central nervous system dysfunction following open-heart surgery. JAMA 1970;212:1333–1340.
336.Stockard, JJ, Bickford, RG, Schauble, JF. Pressure-dependent cerebral ischemia during cardiopulmonary bypass. Neurology 1973;23:521–529.
337.Gold, JP, Charlson, ME, Williams-Russo, P, et al. Improvement of outcomes after coronary artery bypass: A randomized trial comparing intraoperative high vs. low mean arterial pressure. J Thorac Cardiovasc Surg 1995;110:1302–1314.
338.Gottesmann, RF, Hillis, AE, Grega, MA, et al. Early postoperative cognitive dysfunction and blood pressure during coronary artery bypass graft operation. Arch Neurol 2007;64:1111–1114.
339.Dubinsky, RM, Lai, SM. Mortality from combined carotid endarterectomy and coronary artery bypass surgery in the US. Neurology 2007;68:195–197.
340.Breslau, PJ, Fell, G, Ivey, TD, et al. Carotid arterial disease in patients undergoing coronary artery bypass operations. J Thorac Cardiovasc Surg 1981;82:765–767.
341.Turnipseed, WD, Berkhoff, HA, Belzer, FO. Postoperative stroke in cardiac and peripheral vascular disease. Ann Surg 1980;192:365–368.
342.Chimowitz, M. Neurological complications of cardiac surgery. In Caplan, LR, Hurst, JW, Chimowitz, M (eds), Clinical Neurocardiology. New York: Marcel Dekker, 1999, pp 226–257.
343.Furlan, A, Craciun, A. Risk of stroke during coronary artery bypass graft surgery in patients with internal carotid artery disease documented by angiography. Stroke 1985;16:797–799.
344.Von Reutern, G, Hetzel, A, Birnbaum, D, et al. Transcranial Doppler ultrasound during cardiopulmonary bypass in patients with internal carotid artery disease documented by angiography. Stroke 1988;19:674–680.
345.Hise, JH, Nipper, MN, Schnitker, JC. Stroke associated with coronary artery bypass surgery. AJNR Am J Neuroradiol 1991;12:811–814.
346.Barbut, D, Gold, JP. Aortic atheromatosis and risks of cerebral embolization. J Cardiothorac Vasc Anesth 1996;10:24–30.
347.Blauth, CI, Cosgrove, DM, Webb, BW, et al. Atheroembolism from the ascending aorta. An emerging problem in cardiac surgery. J Thorac Cardiovasc Surg 1992;103:1104–1112.
348.Masuda, J, Yutani, C, Ogata, J, et al. Atheromatous embolism to the brain: A clinicopathologic analysis of 15 autopsy cases. Neurology 1994;44:1231–1237.
349.Katz, ES, Tunick, PA, Rusinek, H, et al. Protruding aortic atheromas predict stroke in elderly patients undergoing cardiopulmonary bypass: Experience with intraoperative transesophageal echocardiography. J Am Coll Cardiol 1992;20:70–77.
350.Mills, NL, Everson, CT. Atherosclerosis of the ascending aorta and coronary artery bypass. Pathology, clinical correlates and operative management. J Thorac Cardiovasc Surg 1991;102:546–553.
351.Yao, FSF, Barbut, D, Hager, DN, et al. Detection of aortic emboli by transesophageal echocardiography during coronary artery bypass surgery. J Cardiothorac Vasc Anesth 1996;10:314–317.
352.Gardner, TJ, Horneffer, PJ, Manolio, TA, et al. Stroke following coronary artery bypass grafting: A ten-year study. Ann Thorac Surg 1985;40:574–581.
353.Caplan, LR. Translating what is known about neurological complications of coronary artery bypass graft surgery into action (Editorial). Arch Neurol 2009;66:1062–1064.
354.Warehag, TH, Davila-Roman, VG, Barzilai, B, et al. Management of the severely atherosclerotic aorta during cardiac operations. J Thorac Cardiovasc Surg 1992;103:453–462.
355.Barbut, D, Yao, FS, Hager, DN, et al. Comparison of transcranial Doppler ultrasonography and transesophageal echocardiography during coronary artery bypass surgery. Stroke 1996;27:87–90.
356.Dittrich, R, Ringelstein, EB. Occurrence and clinical impact of microembolic signals during or after cardiosurgical procedures. Stroke 2008;39:503–511.
357.Marshall, WG, Barzilai, B, Kouchoukos, NT, et al. Intraoperative ultrasonic imaging of the ascending aorta. Ann Thorac Surg 1989;48:339–344.
358.Borowicz, I, Goldsborough, M, Selnes, O, McKann, G. Neuropsychologic change after cardiac surgery. A critical review. J Cardiothorac Vasc Anesth 1996;10:105–111.
359.Barbut, D, Hinton, R, Szatrowski, TP, et al. Cerebral emboli detected during bypass surgery are associated with clamp removal. Stroke 1994;25:2398–2402.
360.Hammon, J, Stump, D, Kon, N, et al. Risk factors and solutions for the development of neurobehavioral changes after coronary artery bypass grafting. Ann Thorac Surg 1997;63:1613–1618.
361.Hanson, MR, Hamid, MA, Tomsak, RL, Chou, SS, Leigh, RJ. Selective saccadic palsy caused by pontine lesions: Clinical, physiological, and pathological correlations. Ann Neurol 1986;20:209–217.
362.Tomsak, RL, Volpe, BT, Stahl, JS, Leigh, RJ. Saccadic palsy after cardiac surgery: Visual disability and rehabilitation. Ann NY Acad Sci 2002;956:430–433.
363.Eggers, SDZ, Moster, ML, Cranmer, K. Selective saccadic palsy after cardiac surgery. Neurology 2008;70:318–320.
364.Solomon, D, Ramat, S, Tomsak, RL, et al. Saccadic palsy after cardiac surgery: Characteristics and pathogenesis. Ann Neurol 2007;63:355–365.
365.van Dijk, D, Spoor, M, Hijman, R, et al. for the Octopus Study Group. Cognitive and cardiac outcomes 5 years after off-pump vs. on-pump coronary artery bypass graft surgery. JAMA 2007;297:701–708.
366.Duncan, A, Rumbaugh, C, Caplan, LR. Cerebral embolic disease, a complication of carotid aneurysms. Radiology 1979;133:379–384.
367.Fisher, M, Davidson, R, Marcus, E. Transient focal cortical ischemia as a presenting manifestation of unruptured cerebral aneurysms. Ann Neurol 1980;8:367–372.
368.Pessin, MS, Chimowitz, MI, Levine, SR, et al. Stroke in patients with fusiform vertebrobasilar aneurysms. Neurology 1989;39:16–21.
369.Caplan, LR, Stein, R, Patel, D, et al. Intraluminal clot of the carotid artery detected radiographically. Neurology 1984;34:1175–1181.
370.Perloff, JK. Congenital mitral stenosis, cor triatriatum, congenital pulmonary vein stenosis. In Perloff, JK, Marelli, AJ (eds), The Clinical Recognition of Congenital Heart Disease. Philadelphia: W B Saunders, 1987, pp 169–171.
371.Manning, WJ, Weintraub, RM, Waksmonski, CA, et al. Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study. Ann Intern Med 1995;123:817–822.
372.Fatkin, D, Scalia, G, Jacobs, N, et al. Accuracy of biplane transesophageal echocardiography in detecting left atrial thrombus. Am J Cardiol 1996;77:321–323.
373.Pearson, AC, Labovitz, AJ, Tatineni, S, Gomez, CR. Superiority of transesophageal echocardiography in detecting cardiac source of embolism in patients with cerebral ischemia of uncertain etiology. J Am Coll Cardiol 1991;17:66–72.
374.DeRook, FA, Comess, KA, Albers, GW, Popp, RL. Transesophageal echocardiography in the evaluation of stroke. Ann Intern Med 1992;117:922–932.
375.Daniel, WG, Mugge, A. Transesophageal echocardiography. N Engl J Med 1995;332:1268–1279.
376.Horowitz, DR, Tuhrim, S, Weinberger, J, et al. Transesophageal echocardiography: Diagnostic and clinical applications in the evaluation of the stroke patient. J Stroke Cerebrovasc Dis 1997;6:332–336.
377.Johnson, LL, Pohost, GM. Nuclear cardiology. In Schlant, RC, Alexander, RW (eds), Hurst’s The Heart, 8th ed. New York: McGraw-Hill, 1994, pp 2281–2323.
378.Ezekowiz, MD, Wilson, DA, Smith, EO, et al. Comparison of indium-111 platelet scintigraphy and two-dimensional echocardiography in the diagnosis of left ventricular thrombi. N Engl J Med 1982;306:1509–1513.
379.Daccarett, M, McGann, CJ, Akoum, NW, MacLeod, R, Marrouche, NF. MRI of the left atrium: Predicting clinical outcomes in patients with atrial fibrillation. Exp Rev Cardiovasc Ther 2011;9:105–111.
380.Baher, A, Mowla, A, Kodali, S, et al. Cardiac MRI improves identification of etiology of acute ischemic stroke. Cerebrovasc Dis 2014;37:277–284.
381.Hur, J, Kim, YJ, Lee, HJ, et al. Left atrial appendage thrombi in stroke patients: Detection with two-phase cardiac CT angiography versus transesophageal echocardiography. Radiology 2009;251:683–690.
382.Hur, J, Kim, YJ, Lee, HJ, et al. Cardioembolic stroke: Dual-energy cardiac CT for differentiation of left atrial appendage thrombus and circulatory stasis. Radiology 2012;263:688–695.
383.Romero, J, Husain, SA, Kelesidis, I, Sanz, J, Medina, HM, Garcia, MJ. Detection of left atrial appendage thrombus by cardiac computed tomography in patients with atrial fibrillation: A meta-analysis. Circ Cardiovasc Imaging 2013;6:185–194.
384.Romero, J, Cao, JJ, Garcia, MJ, Taub, CC. Cardiac imaging for assessment of left atrial appendage stasis and thrombosis. Nat Rev Cardiol 2014;11:470–480.
385.Caplan, LR, Feinberg, WM, Fisher, MJ, del Zoppo, GJ. The blood. In Caplan, LR (ed), Brain Ischemia. Basic Concepts and Clinical Relevance. London: Springer, 1995, pp 83–126.
386.Caplan, LR. Treatment of the acute embolic event. In Caplan, LR, Manning, W (eds), Brain Embolism. New York: Informa Healthcare, 2006, pp 277–288.
387.Furlan, A, Higashida, R, Wechsler, L, et al. Intraarterial prourokinase for acute ischemic stroke. The PROACT II Study: A randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003–2011.
388.Fisher, CM, Perlman, A. The nonsudden onset of cerebral embolism. Neurology 1967;17:1025–1032.
389.Melski, J, Caplan, LR, Mohr, JP, Geer, D, Bleich, H. Modeling the diagnosis of stroke at two hospitals. MD Computing 1989;6:157–163.
390.Staroselskaya, I, Chaves, C, Silver, B, et al. Relationship between magnetic resonance arterial patency and perfusion-diffusion mismatch in acute ischemic stroke and its potential clinical use. Arch Neurol 2001;58:1069–1074.
391.Derex, L, Nighoghossian, N, Hermier, M, Adeleine, P, Froment, JC, Trouillas, P. Early detection of cerebral arterial occlusion on magnetic resonance angiography: Predictive value of the baseline NIHSS score and impact on neurological outcome. Cerebrovasc Dis 2002;13:225–229.
392.Parsons, MW, Barber, PA, Chalk, J, et al. Diffusion- and perfusion-weighted response to thrombolysis in stroke. Ann Neurol 2002;51:28–37.
393.Campbell, BC, Christensen, S, Parsons, MW, et al. for the EPITHET and DEFUSE Investigators. Advanced imaging improves prediction of hemorrhage after stroke thrombolysis. Ann Neurol 2013;73:510–519.
394.Pessin, MS, del Zoppo, GJ, Furlan, AJ. Thrombolytic treatment in acute stroke: Review and Update of Selected Topics in Cerebrovascular Disease. 19th Princeton Conference, 1994. Boston: Butterworth–Heinemann, 1995, pp 409–418.
395.Caplan, LR. Caplan’s Stroke, a Clinical Approach. Boston, Butterworth–Heinemann, 2000, pp 124–130.
396.Caplan, LR. Thrombolysis 2004: The good, the bad, and the ugly. Rev Neurol Dis 2004;1:16–26.
397.Christoforidis, G, Mohammad, Y, Bourekas, E, Slivka, A. Initial severity of angiographic occlusion predicts subsequent volume of cerebral infarction following intra-arterial thrombolysis in acute ischemic stroke. Neurology 2004;62 (Suppl 5): A449.
398.Toni, D, Fiorelli, M, Zanette, EM, et al. Early spontaneous improvement and deterioration of ischemic stroke patients: A serial study with transcranial Doppler ultrasonography. Stroke 1998;29:1144–1148.
399.Lewandowski, C, Frankel, M, Tomsick, T, et al. Combined intravenous and intraarterial r-tPA versus intra-arterial therapy of acute ischemic stroke: Emergency Management of Stroke (EMS) Bridging Trial. Stroke 1999;30:2598–2605.
400.IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The Interventional Management of Stroke Study. Stroke 2004;35:904–912.
401.Hausegger, K, Hauser, M, Kau, T. Mechanical thrombectomy with stent retrievers in acute ischemic stroke. Cardiovasc Intervent Radiol 2014;37:863–74.
402.Ciccone, A, Valvassori, L. Endovascular treatment for acute ischemic stroke. N Engl J Med 2013;368:2433–2434.
403.Berlis, A, Lutsep, H, Barnwell, S. Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization. Stroke 2004;35:1112–1116.
404.Hacke, W. The dilemma of reinstituting anticoagulation for patients with cardioembolic sources and intracranial hemorrhage: How wide is the strait between Skylla and Karybdis? Arch Neurol 2000;57:1682–1684.
405.Phan, TG, Koh, M, Wijdicks, EF. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol 2000;57:1710–1713.
406.O’Brien, MD. Ischemic cerebral edema in brain ischemia. In Caplan, LR (ed.), Basic Concepts and Clinical Relevance, London: Springer-Verlag, 1995, pp 43–50.
407.Parisi, DM, Koval, K, Egol, K. Fat embolism syndrome. Am J Orthop (Belle Mead NJ) 2002;31:507–512.
408.Bulger, E, Smith, DG, Maier, RV, Jurkovich, G. Fat embolism syndrome. A 10-year review. Arch Surg 1997;132:435–439.
409.Sevitt, S. Fat Embolism. London: Butterworth & Co., 1962.
410.Dines, DE, Burgher, LW, Okazaki, H. The clinical and pathological correlation of fat embolism syndrome. Mayo Clin Proc 1975;50:407–411.
411.Jacobson, DM, Terrence, CF, Reinmuth, OM. The neurologic manifestations of fat embolism. Neurology 1986;36:847–851.
412.Hill, JD, Aguilar, MJ, Baranco, AP, Gerbode, F. Neuropathological manifestations of cardiac surgery. Ann Thorac Surg 1969;7:409–517.
413.Ghatal, NR, Sinnenberg, RJ, DeBlois, GG. Cerebral fat embolism following cardiac surgery. Stroke 1983;14:619–621.
414.Charache, S, Page, DL. Infarction of bone marrow in sickle cell disorders. Ann Intern Med 1967;67:1195–1200.
415.Vichinsky, E, Williams, K, Das, M, et al. Pulmonary fat embolism: A distinct cause of severe acute chest syndrome in sickle cell anemia. Blood 1994;83:3107–3112.
416.Shelley, WM, Curtis, EM. Bone marrow and fat embolism in sickle cell anemia and sickle cell-hemoglobin C disease. Bull Johns Hopkins Hosp 1958;103:8–25.
417.Chmel, H, Bertles, J. Hemoglobin S/C disease in a pregnant woman with crisis and fat embolization syndrome. Am J Med 1975;58:563–566.
418.Yoo, KM, Yoo, BG, Kim, KS, Lee, SU, Han, BH. Cerebral lipiodol embolism during transcatheter arterial chemoembolism. Neurology 2004;63:181–183.
419.Qian, Y, Ances, BM, Pruitt, A, Choi, B, Moonis, G. Intracranial fat embolization due to baclofen pump. Neurology 2005;64:919.
420.Simon, A, Ulmer, JL, Strottman, JM. Contrast-enhanced MR imaging of cerebral fat embolism: Case report and review of the literature. AJNR 2003;24:97–101.
421.Forteza, AM, Rabinstein, A, Koch, S, et al. Endovascular closure of a patent foramen ovale in the fat embolism syndrome. Changes in the embolic pattern as detected by transcranial Doppler. Arch Neurol 2002;59:455–459.
422.Forteza, AM, Koch, S, Romano, JG, et al. Transcranial Doppler detection of fat emboli. Stroke 1999;30:2687–2691.
423.Guillevin, R, Vallee, JN, Demeret, S, et al. Cerebral fat embolism: Usefulness of magnetic resonance spectroscopy. Ann Neurol 2005;57:434–439.
424.Chastre, J, Fagon, J-Y, Soler, P, et al. Bronchoalveolar lavage for rapid diagnosis of the fat embolism syndrome in trauma patients. Ann Intern Med 1990;113:583–588.
425.Godeau, B, Schaeffer, A, Bachir, D, et al. Bronchoalveolar lavage in adult sickle cell patients with acute chest syndrome: Value for diagnostic assessment of fat embolism. Am J Resp Care Med 1996;153:1691–1696.
426.Kamenar, E, Burger, PC. Cerebral fat embolism: A neuropathological study of a microembolic state. Stroke 1980;11:477–484.
427.Menkin, M, Schwartzman, RJ. Cerebral air embolism. Report of five cases and review of the literature. Arch Neurol 1977;34:169–170.
428.Valentino, R, Hilbert, G, Vargas, F, Gruson, D. Computed tomographic scan of massive cerebral air embolism. Lancet 2003;361:1848.
429.Demaerel, P, Gevers, A-M, De Brueker, Y, Sunaert, S, Wilms, G. Stroke caused by cerebral air embolism during endoscopy. Gastrointest Endosc 2003;1:134–135.
430.Weber, M-A, Fiebach, JB, Lichy, MP, Schwark, C, Grau, A. Bilateral cerebral air embolism. J Neurol 2003;250:1115–1117.
431.Hodics, T, Linfante, I. Cerebral air embolism. Neurology 2003;60:112.
432.Hertz, JA, Schinco, MA, Frykberg, ER. Extensive pneumocranium. J Trauma 2002;52:188.
433.Laskey, AL, Dyer, C, Tobias, JD. Venous air embolism during home infusion therapy. Pediatrics 2002;109:e15.
434.Gei, AF, Vadhera, , Hankins, GDV. Embolism during pregnancy: Thrombus, air, and amniotic fluid. Anesthesiol Clin North America 2003;21:165–182.
435.Malinow, AM, Naulty, JS, Hunt, CO, et al. Precordial ultrasonic monitoring during cesarean delivery. Anesthesiology 1987;66:816–819.
436.Spencer, MP, Campbell, SD. Development of bubbles in venous and arterial blood during hyperbaric decompression. Bull Mason Clin 1968;22:26–32.
437.Gillen, HW. Symptomatology of cerebral gas embolism. Neurology 1968;18:507–512.
438.van Hulst, RA, Klein, J, Lachman, B. Gas embolism: Pathophysiology and treatment. Clin Physiol Funct Imaging 2003;23:237–246.
439.Cantais, E, Louge, P, Suppini, A, Foster, PP, Palmier, B. Right-to-left shunt and risk of decompression illness with cochleovestibular and cerebral symptoms in divers: Case control study in 101 consecutive dive accidents. Crit Care Med 2003;31:84–88.
440.Jeon, S-B, Kim, JS, Lee, DK, Kang, D-W, Kwon, SU. Clinicoradiological characteristics of cerebral air embolism. Cerebrovasc Dis 2007;23:459–462.
441.Yeh, T, Austin, EH, Sehic, A, Edmonds, HL. Rapid recognition and treatment of cerebral air embolism: The role of neuroimaging. J Thor Cardiovasc Surg 2003;126:589–591.
442.Lefkovitz, NW, Roessman, U, Kori, S. Major cerebral infarction from tumor embolus. Stroke 1986;17:555–557.
443.Banerjee, AK, Chopra, JS. Cerebral embolism from a thyroid carcinoma. Arch Neurol 1972;27:186–187.
444.Kase, CS, White, R, Vinson, TL, Eichelberger, RP. Shotgun pellet embolus to the middle cerebral artery. Neurology 1981;31:458–461.
445.Yaari, R, Ahmadi, J, Chang, GY. Cerebral shotgun pellet embolism. Neurology 2000;54:1487.
446.Duncan, I, Fourie, PA. Embolization of a bullet in the internal carotid artery. AJR Am J Roentgenol 2002;178:1572–1573.
447.Langenbach, M, Leopold, H-C, Hennerici, M. Neck trauma with embolization of the middle cerebral artery by a metal splinter. Neurology 1990;40:552–553.
448.Dato, GMA, Arsianian, A, Di Marzio, P, Filosso, PL, Ruffini, E. Posttraumatic and iatrogenic foreign bodies in the heart: Report of fourteen cases and review of the literature. J Thor Cardiovascular Surg 2003;126:408–414.
449.Crie, JS, Hajar, R, Folger, G. Umbilical catheter masquerading at echocardiography as a left atrial mass. Clin Cardiol 1989;12:728–730.
450.Mattox, KL, Beall, AC, Ennix, CL, DeBakey, ME. Intravascular migratory bullets. Am J Surg 1979;137:192–195.
451.Caplan, LR, Thomas, C, Banks, G. Central nervous system complications of “Ts and blues” addiction. Neurology 1982;32:623–628.
452.Caplan, LR, Hier, DB, Banks, G. Current concepts of cerebrovascular disease – stroke: Stroke and drug abuse. Stroke 1982;27:869–73.
453.Atlee, W. Talc and cornstarch emboli in the eyes of drug abusers. JAMA 1972;219:49–51.
454.Mizutami, T, Lewis, R, Gonatas, N. Medial medullary syndrome in a drug abuser. Arch Neurol 1980;37:425–428.
455.Chillar, RK, Jackson, AL, Alaan, L. Hemiplegia after intracarotid injection of methylphenidate. Arch Neurol 1982;39:598–599.